EMED vs EME: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

EME has stronger fundamentals based on our AI analysis.

EMED
Electromedical Technologies, Inc
STRONG SELL
95%
Confidence
VS
EME
EMCOR Group, Inc.
STRONG BUY
85%
Confidence

EMED vs EME Fundamental Comparison

Metric EMED EME
Revenue $570,415.0 $17.0B
Net Income $-1.3M $1.3B
Net Margin -233.1% 7.5%
ROE N/A 34.6%
ROA -233.8% 13.7%
Current Ratio 0.07x 1.22x
Debt/Equity N/A 0.00x
EPS $0.00 $28.19

Green = Better metric | Red = Weaker metric

View Full EMED Analysis →
View Full EME Analysis →

You Might Also Compare

EMED vs AAPL EME vs MSFT EMED vs GOOGL EME vs AMZN

EMED vs EME: Frequently Asked Questions

Is EMED or EME a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), EME has stronger fundamentals. EMED is rated STRONG SELL (95% confidence) while EME is rated STRONG BUY (85% confidence). This is not investment advice.

How does EMED compare to EME fundamentally?

Electromedical Technologies, Inc has ROE of N/A vs EMCOR Group, Inc.'s 34.6%. Net margins are -233.1% vs 7.5% respectively.

Which stock pays higher dividends, EMED or EME?

EMED has a dividend yield of N/A or no dividend while EME has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in EMED or EME for long term?

For long-term investing, consider that EMED has STRONG SELL rating with 95% confidence, while EME has STRONG BUY rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about EMED vs EME?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EMED vs EME, the AI consensus favors EME based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.